Search Results - "Couderc, L.J."

  • Showing 1 - 19 results of 19
Refine Results
  1. 1

    Efficacy and safety of gefitinib during pregnancy: Case report and literature review by Gil, S, Goetgheluck, J, Paci, A, Broutin, S, Friard, S, Couderc, L.J, Ayoubi, J.M, Picone, O, Tcherakian, C

    Published in Lung cancer (Amsterdam, Netherlands) (01-09-2014)
    “…Highlights • During pregnancy gefitinib appears to have a good pharmacological profile. • Residual concentration for gefitinib for the mother is within the…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Efficiency of immunoglobulin G replacement therapy in common variable immunodeficiency: correlations with clinical phenotype and polymorphism of the neonatal Fc receptor by Gouilleux‐Gruart, V., Chapel, H., Chevret, S., Lucas, M., Malphettes, M., Fieschi, C., Patel, S., Boutboul, D., Marson, M.‐N., Gérard, L., Lee, M., Watier, H., Oksenhendler, E., Galicier, L., Fermand, J.P., Viallard, J.F., Jaccard, A., Hoarau, C., Lebranchu, Y., Bérezné, A., Mouthon, L., Karmochkine, M., Georgin‐Lavialle, S., Schleinitz, N., Durieu, I., Nove‐Josserand, R., Chanet, V., Le‐Moing, V., Just, N., Salanoubat, C., Jaussaud, R., Suarez, F., Hermine, O., Solal‐Celigny, P., Hachulla, E., Sanhes, L., Gardembas, M., Pellier, I., Tisserant, P., Pavic, M., Bonnotte, B., Haroche, J., Amoura, Z., Alric, L., Thiercelin, M.F., Tetu, L., Adoue, D., Bordigoni, P., Perpoint, T., Sève, P., Rohrlich, P., Pasquali, J.L., Soulas, P., Couderc, L.J., Catherinot, E., Giraud, P., Baruchel, A., Deleveau, I., Chaix, F., Donadieu, J., Tron, F., Larroche, C., Blanc, AP, Masseau, A., Hamidou, M., Kanny, G., Morisset, M., Millot, F., Fain, O., Borie, R., Perlat, A., Martinez, V., Bienvenu, B., Debré, P., Mouillot, G., Théodorou, I., Rabian, C., Carmagnat, M., Vince, N., Bono, C.

    Published in Clinical and experimental immunology (01-02-2013)
    “…Summary Treatment of common variable immunodeficiency disorders (CVID) is based on replacement therapy using intravenous (i.v.) or subcutaneous (s.c.)…”
    Get full text
    Journal Article
  4. 4

    Exclusion of Patients with a Severe T-Cell Defect Improves the Definition of Common Variable Immunodeficiency by Bertinchamp, Rémi, MD, Gérard, Laurence, MD, Boutboul, David, MD, Malphettes, Marion, MD, Fieschi, Claire, MD, PhD, Oksenhendler, Eric, MD

    “…Background In 2014, the European Society for Immune Deficiencies (ESID) revised the common variable immunodeficiency (CVID) diagnosis criteria by incorporating…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19